Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency Dec 09, 2019
Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Nov 12, 2019
Fortress Biotech Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Nov 12, 2019
Checkpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 08, 2019
